Synribo FDA Approved Drugs
SYNRIBO [Omacetaxine MepesuccinateC29H39NO9]
RX
- 3.5mg/vial (subcutaneous powder)
Teva Pharms IntlOct 26, 2012
- Treatment of leukemia.
- Treatment of patients with tyrosine kinase inhibitor (tki) resistant or intolerant chronic myeloid/myelogenous leukemia (cml).
WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.